Serum S100B: a potential biomarker for suicidality in adolescents?
BACKGROUND: Studies have shown that patients suffering from depression or schizophrenia often have immunological alterations that can be detected in the blood. Others reported a possible link between inflammation, a microgliosis and the blood-brain barrier (BBB) in suicidal patients. Serum S100B is...
Main Authors: | Tatiana Falcone, Vincent Fazio, Catherine Lee, Barry Simon, Kathleen Franco, Nicola Marchi, Damir Janigro |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2010-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC2885416?pdf=render |
Similar Items
-
Is Salivary S100B a Biomarker of Traumatic Brain Injury? A Pilot Study
by: Damir Janigro, et al.
Published: (2020-06-01) -
Diagnostic biomarker kinetics: how brain-derived biomarkers distribute through the human body, and how this affects their diagnostic significance: the case of S100B
by: Robert Murcko, et al.
Published: (2022-05-01) -
Extracranial sources of S100B do not affect serum levels.
by: Nancy Pham, et al.
Published: (2010-09-01) -
GFAP and S100B: What You Always Wanted to Know and Never Dared to Ask
by: Damir Janigro, et al.
Published: (2022-03-01) -
Peripheral Blood and Salivary Biomarkers of Blood–Brain Barrier Permeability and Neuronal Damage: Clinical and Applied Concepts
by: Damir Janigro, et al.
Published: (2021-02-01)